Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Placebo and nocebo effects in the neurological practice.
Attitude towards physical activity in patients with multiple sclerosis: a cohort study.
DOPAMINE AND T CELLS: Receptors, Direct and Potent Effects, Endogenous Production and Abnormalities in Autoimmune, Neurological and Psychiatric Diseases.
Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.
Epidemiology of multiple sclerosis: results from a large observational study in the UK.
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.
Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption.
Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis.
Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.
Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
[Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.
Idiopathic inflammatory demyelinating disorders of the central nervous system in children.
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
The use of valproic acid and multiple sclerosis.
Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple Sclerosis.
Endogenous Two-Photon Excited Fluorescence Provides Label-Free Visualization of the Inflammatory Response in the Rodent Spinal Cord.
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
Symptomatic management in multiple sclerosis.
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Iron chelation in the treatment of neurodegenerative diseases.
Pages
« first
‹ previous
…
514
515
516
517
518
519
520
521
522
…
next ›
last »